Sigrid Therapeutics

Are you curious to find out how our research can transform the way we prevent and treat type 2 diabetes? Then take a moment to listen to Sigrid's Co-founder and Chief Scientific Officer Professor Tore Bengtsson. vimeo.com/315530514

If you want to go global, go local! uppgang.com/start/de-kan-b…

Listen to our CTO, Dr Eric Johnston, to find out how SiPore15 can help prevent type 2 diabetes. vimeo.com/315530408

#Finland’s Crown CRO and Sweden’s Sigrid Therapeutics have agreed to join forces to cure metabolic disorders in the early phase of #prediabetes ow.ly/7O6230nB54s #CrownCRO @SigridThx @unihelsinki #medicalresearch #diabetes #metabolism #SiPore15 #Sweden #clinicaltrial

Sigrid Therapeutics is a clinical stage biotech Company launching a clinical trial with a new product to prevent diabetes. Interested in participating? Go to our homepage, sigridthx.com, for more information!

Stockholm, February 5th 2019, Sigrid Therapeutics AB (Sigrid) and Crown CRO (Crown) today announced the initiation of the STAR clinical trial, testing the efficacy and safety of the orally-administered medical device SiPore15™. Visit sigridthx.com for more information!

On October 19th, Sigrid Therapeutics AB (Sigrid) won the Start Jerusalem (JLM) pitch competition organized by the Embassy of Israel in Stockholm in association with the Sweden-Israel Chamber of Commerce and Sweden’s innovation agency Vinnova!

On 10th of September, Sigrid Therapeutics was voted the winner of the Startup Challenge Award at the Nordic Life Science Days!